{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02485",
      "entity_text" : "NF-kappaB p65",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:O95994",
      "entity_text" : "AGR2",
      "entity_type" : "protein"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "The results indicate that AGR2 may reduce intestinal barrier damage by inhibiting the activation of NF-kappaB p65.",
  "reading_complete" : "2020-08-03T14:46:21Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T14:45:32Z",
  "trigger" : "reduce",
  "evidence" : [ "AGR2 may reduce intestinal barrier damage by inhibiting the activation of NF-kappaB p65" ],
  "pmc_id" : "5403182",
  "score" : 0
}